PhytoHealth Corporation (TPE:4108)
Taiwan · Delayed Price · Currency is TWD 10.90
+0.15 (1.40%)
Aug 19, 2026, 1:30 PM CST
PhytoHealth Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 143.43 | 134.58 | 153.56 | 162.49 | 135.47 | 168.94 | |
Revenue Growth | 3.62% | -12.36% | -5.49% | 19.95% | -19.81% | 84.01% |
Cost of Revenue | 95.96 | 93.28 | 89.56 | 94.85 | 78.43 | 90.62 |
Gross Profit | 47.47 | 41.29 | 64.01 | 67.64 | 57.03 | 78.31 |
Selling, General & Admin | 85.03 | 89.72 | 95.68 | 96.73 | 94.23 | 90.06 |
Research & Development | 126.87 | 126.15 | 128.51 | 92.59 | 119.52 | 120.47 |
Operating Expenses | 211.9 | 215.87 | 224.19 | 189.32 | 213.7 | 210.42 |
Operating Income | -164.42 | -174.58 | -160.18 | -121.68 | -156.66 | -132.11 |
Interest Expense | -0.42 | -0.38 | -0.34 | -0.34 | -0.31 | -0.41 |
Interest & Investment Income | 57.18 | 49.72 | 45.87 | 41.19 | 36.31 | 29.66 |
Currency Exchange Gain (Loss) | 1.81 | 0.38 | 0.11 | 0.2 | 1.61 | 2.09 |
Other Non Operating Income (Expenses) | 8.06 | 13.49 | 6.09 | 6.58 | 4.27 | 5.29 |
EBT Excluding Unusual Items | -97.79 | -111.37 | -108.45 | -74.05 | -114.78 | -95.48 |
Gain (Loss) on Sale of Investments | 5.51 | 1.45 | 0.1 | 0.07 | 0.07 | 0.04 |
Gain (Loss) on Sale of Assets | -0.12 | -0.22 | -0.19 | -0.17 | -0.01 | -0.08 |
Other Unusual Items | - | 0.02 | - | 0 | - | - |
Pretax Income | -92.41 | -110.11 | -108.53 | -74.15 | -114.72 | -95.52 |
Income Tax Expense | 0.01 | -0.02 | - | - | - | - |
Earnings From Continuing Operations | -92.42 | -110.1 | -108.53 | -74.15 | -114.72 | -95.52 |
Minority Interest in Earnings | 49.05 | 51.9 | 35.03 | 27.03 | 35.31 | 17.8 |
Net Income | -43.37 | -58.2 | -73.5 | -47.12 | -79.41 | -77.72 |
Net Income to Common | -43.37 | -58.2 | -73.5 | -47.12 | -79.41 | -77.72 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 199 | 199 | 199 | 199 | 199 | 196 |
Shares Outstanding (Diluted) | 199 | 199 | 199 | 199 | 199 | 196 |
Shares Change | - | - | - | - | 1.49% | 19.61% |
EPS (Basic) | -0.22 | -0.29 | -0.37 | -0.24 | -0.40 | -0.40 |
EPS (Diluted) | -0.22 | -0.29 | -0.37 | -0.24 | -0.40 | -0.40 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -19.11 | -45.26 | -54.85 | -59.68 | -61.55 | -81.46 |
Free Cash Flow Per Share | -0.10 | -0.23 | -0.28 | -0.30 | -0.31 | -0.42 |
Gross Margin | 33.10% | 30.68% | 41.68% | 41.63% | 42.10% | 46.36% |
Operating Margin | -114.63% | -129.73% | -104.31% | -74.88% | -115.65% | -78.20% |
Profit Margin | -30.24% | -43.25% | -47.86% | -29.00% | -58.62% | -46.00% |
Free Cash Flow Margin | -13.32% | -33.63% | -35.72% | -36.73% | -45.44% | -48.22% |
EBITDA | -127.59 | -136.68 | -118.32 | -79.16 | -114.85 | -90.16 |
EBITDA Margin | -88.95% | -101.56% | -77.05% | -48.72% | -84.78% | -53.37% |
D&A For EBITDA | 36.83 | 37.91 | 41.87 | 42.52 | 41.82 | 41.95 |
EBIT | -164.42 | -174.58 | -160.18 | -121.68 | -156.66 | -132.11 |
EBIT Margin | -114.63% | -129.73% | -104.31% | -74.88% | -115.65% | -78.20% |